Rapid latex agglutination test for rubella antibody

Area of Science:

• Immunology
• Diagnostic Microbiology

Background:

• Rubella antibody detection is crucial for assessing immunity and guiding vaccination strategies.
• Standard methods like hemagglutination inhibition (HI) and enzyme-linked immunosorbent assay (ELISA) are established but can be time-consuming.
• A rapid, point-of-care test for rubella antibody detection would be beneficial for clinical decision-making.

Purpose of the Study:

• To evaluate the performance of the latex agglutination card test (Rubascan) for rubella antibody detection.
• To compare Rubascan results with standard HI and ELISA methods.
• To assess the reliability of Rubascan for different antibody titers and sample types.

Main Methods:

• Comparison of latex agglutination test (Rubascan) with hemagglutination inhibition (HI) and enzyme-linked immunosorbent assay (ELISA).
• Analysis of agreement for sera with varying rubella antibody titers.
• Evaluation of results using both venous sera and capillary plasma.

Main Results:

• Complete agreement between Rubascan and HI/ELISA for titers >/=16.
• Approximately 25% false-negative rate for Rubascan with low antibody levels detected by ELISA.
• Approximately 3% false-positive rate for Rubascan with negative ELISA results.
• Additional false negatives observed when using capillary plasma instead of venous sera for low titers.

Conclusions:

• Rubascan is a simple, rapid test suitable for physician offices and immunization campaigns.
• Careful interpretation is needed due to false-negative and false-positive rates, especially with low antibody levels.
• Confirmation with specific methods is recommended for critical cases, such as pregnant women or women of childbearing age, particularly when Rubascan results are negative.